BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15956757)

  • 1. Coevolution of the relaxin-like peptides and their receptors.
    Wilkinson TN; Speed TP; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():534-9. PubMed ID: 15956757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the signaling system in relaxin-family peptides.
    Hsu SY; Semyonov J; Park JI; Chang CL
    Ann N Y Acad Sci; 2005 May; 1041():520-9. PubMed ID: 15956755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors for relaxin family peptides.
    Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():61-76. PubMed ID: 15956688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of the relaxin peptide family and their receptors.
    Wilkinson TN; Bathgate RA
    Adv Exp Med Biol; 2007; 612():1-13. PubMed ID: 18161477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane receptors: structure and function of the relaxin family peptide receptors.
    Kong RC; Shilling PJ; Lobb DK; Gooley PR; Bathgate RA
    Mol Cell Endocrinol; 2010 May; 320(1-2):1-15. PubMed ID: 20138959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
    Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW
    Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
    Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
    J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in relaxin-3-related research.
    Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW
    Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxin research in the postgenomic era.
    Kawamura K; Sudo S; Kumagai J; Pisarska M; Hsu SY; Bathgate R; Wade J; Hsueh AJ
    Ann N Y Acad Sci; 2005 May; 1041():1-7. PubMed ID: 15956679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
    Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the rat INSL3 receptor.
    Scott DJ; Fu P; Shen PJ; Gundlach A; Layfield S; Riesewijk A; Tomiyama H; Hutson JM; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():13-6. PubMed ID: 15956681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity.
    Muda M; He C; Martini PG; Ferraro T; Layfield S; Taylor D; Chevrier C; Schweickhardt R; Kelton C; Ryan PL; Bathgate RA
    Mol Hum Reprod; 2005 Aug; 11(8):591-600. PubMed ID: 16051677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
    Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
    Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like factor 3: where are we now?
    Ivell R; Hartung S; Anand-Ivell R
    Ann N Y Acad Sci; 2005 May; 1041():486-96. PubMed ID: 15956750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin family peptide receptors--from orphans to therapeutic targets.
    van der Westhuizen ET; Halls ML; Samuel CS; Bathgate RA; Unemori EN; Sutton SW; Summers RJ
    Drug Discov Today; 2008 Aug; 13(15-16):640-51. PubMed ID: 18675759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic targeting of relaxin and insl3 signaling in mice.
    Feng S; Bogatcheva NV; Kamat AA; Agoulnik AI
    Ann N Y Acad Sci; 2005 May; 1041():82-90. PubMed ID: 15956690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on soluble ectodomain proteins of relaxin (LGR7) and insulin 3 (LGR8) receptors.
    Yan Y; Cai J; Fu P; Layfield S; Ferraro T; Kumagai J; Sudo S; Tang JG; Giannakis E; Tregear GW; Wade JD; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():35-9. PubMed ID: 15956685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR7-truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro.
    Scott DJ; Tregear GW; Bathgate RA
    Ann N Y Acad Sci; 2005 May; 1041():22-6. PubMed ID: 15956683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-relaxin family peptide signaling and receptors in mouse brain membranes and neuronal cells.
    Ortinau S; Lin F; Wade JD; Tregear GW; Bathgate RA; Gundlach AL
    Ann N Y Acad Sci; 2005 May; 1041():211-5. PubMed ID: 15956710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.